Table 1

HLA class I frequencies of serologically typed patients with hepatitis C virus (HCV) induced end stage liver disease versus blood and organ donors (control group 1)

		Blood and organ donors				HCV induced end stage liver cirrhosis		p Value
		n	%			n	%	p Value
A1	82	24.8		13	18.8	NS
A2	176	53.2		32	46.4	NS
A3	99	29.9		14	20.3	NS
A9	66	19.9		20	29.0	NS
A10	42	12.7		6	8.7	NS
A11	31	9.4		10	14.5	NS
A19	60	18.1		21	30.4	0.032
A28	34	10.3		8	11.6	NS
	331			69

B5	48	14.5		7	10.1	NS
B7	88	26.6		16	23.2	NS
B8	51	15.4		16	23.2	NS
B12	96	29.0		24	34.8	NS
B13	22	6.6		7	10.1	NS
B14	16	4.8		3	4.3	NS
B15	48	14.5		6	8.7	NS
B16	34	10.3		2	2.9	NS
B17	27	8.2		5	7.2	NS
B18	33	10.0		4	5.8	NS
B21	17	5.1		4	5.8	NS
B22	20	6.0		3	4.3	NS
B27	22	6.6		5	7.2	NS
B35	47	14.2		17	24.6	0.049
B37	6	1.8		5	7.2	0.035
B40	48	14.5		7	10.1	NS
B41	4	1.2			0.0	NS
B42	3	0.9			0.0	NS
B47		0.0			0.0	NS
B53		0.0			0.0	NS
B70	2	0.6			0.0
	331	100.0		69

Cw1	26	8.7		3	4.7	NS
Cw2	27	9.1		4	6.3	NS
Cw3	97	32.6		14	21.9	NS
Cw4	59	19.8		21	32.8	0.035
Cw5	46	15.4		11	17.2	NS
Cw6	54	18.1		18	28.1	NS
Cw7	140	47.0		27	42.2	NS
Cw8	11	3.7		1	1.6	NS
	298			64